Dr. Adam Muzychuk

Dr. Adam Muzychuk Calgary Ophthalmologist (MD) with interests in:
• Refractive & Laser Vision Correction
• Cataract Surgery & Anterior Segment

Had an incredible evening discussion with colleagues alongside my good friends , ,  and  on some of the latest IOL techn...
06/23/2025

Had an incredible evening discussion with colleagues alongside my good friends , , and on some of the latest IOL technologies. Thank you !

I’m pleased to share our latest publication, the world’s first clinical trial on this novel FVR IOL, “Efficacy and Safet...
06/11/2025

I’m pleased to share our latest publication, the world’s first clinical trial on this novel FVR IOL, “Efficacy and Safety Evaluation of a New Full Visual Range versus Monofocal IOL in Cataract Patients: A Randomized, Controlled Canadian Clinical Trial,” published online ahead-of-print today in JCRS.

This multi-centre, double-masked clinical trial, conducted at nine sites across Canada, is an in-platform comparison of a novel, continuous full visual range (FVR) IOL with smoothed diffractive echelettes and a monofocal control (enVista Envy vs enVista monofocal).

🔍 Some Highlights from This Study:
✅ Non-inferior distance vision to the monofocal control
✅ Superior intermediate and near vision (p < 0.0001)
✅ Overall binocular defocus curve performance of 3.5D of continuous range at or above 0.2 logMAR, compared to ~2D with the monofocal
✅ No statistically significant difference in the percentage of patients reporting “None” or “A Little” bothersomeness to glare, halos, or starbursts at 6 months on a directed, validated, non-proprietary, Rasch-calibrated questionnaire (QoV)
✅ 91.8% of patients reporting spectacle independence for near vision tasks

🧠 Several novel IOL design features likely contributed to these findings:
• Smoothed-edge diffractive echelettes
• Distance-dominant design under mesopic conditions
• Novel apodization pattern

🌙 Will patients be able to read in dim lighting?
✅ 84.3% of patients reported “No” or “A little” difficulty “Seeing objects close to you in poor or dim lighting”

Thank you to my co-author Dr. Paul Harasymowycz, MD, our co-investigators at nine sites across Canada, and to the sponsor, Bausch + Lomb — particularly their engineering, research, and medical affairs teams.

📄 Read the article (Open Access): http://bit.ly/4l6UBUZ

Aspire is in Canada 🇨🇦 Today we introduced Aspire to Western Canada, a novel intraocular lens implant with enhanced inte...
05/30/2025

Aspire is in Canada 🇨🇦

Today we introduced Aspire to Western Canada, a novel intraocular lens implant with enhanced intermediate on the enVista platform. Our colleagues in the US have been sharing their experiences with this lens for over a year, and having seen promising data presented at meetings, it’s a technology we’re excited to discuss with our patients following Health Canada approval.

Patients have more options than ever to consider with their surgeon to meet their goals for surgery.

Thank you to our amazing team at , our partners at , and Jodi Toews with !

The OR business is booming for Calgary balloon stores.

🇨🇦 Pleased to share that on May 13th, 2025, I performed Canada’s very first TECNIS Odyssey full visual range implants at...
05/26/2025

🇨🇦 Pleased to share that on May 13th, 2025, I performed Canada’s very first TECNIS Odyssey full visual range implants at the Gimbel Eye Centre in Calgary.

The speed at which advancements are being introduced reflects the remarkable dedication of engineers, researchers, manufacturers, and surgeons worldwide—all united by a common purpose: advancing patient care through innovation.

I’m immensely grateful to our patients who trust us to deliver the latest technologies as soon as they become available, and to our exceptional clinic, technical and operating room teams.

Thank you, !

Kicked off spring with a trip to the inaugural Whistler Cataract and Retina Update to serve as guest faculty, discussing...
05/08/2025

Kicked off spring with a trip to the inaugural Whistler Cataract and Retina Update to serve as guest faculty, discussing evidence-based management of astigmatism, IOL formulas and calculations.

This meeting was incredibly well organized in its first year, in a stunning location, with amazing discussions at the intersection of cataract and retina surgery (not to mention the legendary Whistler aprés). Congratulations to the organizers, Drs. Heather O’Donnell, Andrea Butler, Bryon McKay and the scientific planning committee.

Definitely a meeting to watch in the coming years.

+28C in the Okanagan Valley! 🥵 Heading to the airport after meetings yesterday and today discussing the TECNIS PureSee f...
05/02/2025

+28C in the Okanagan Valley! 🥵 Heading to the airport after meetings yesterday and today discussing the TECNIS PureSee fully refractive EDOF. Thank you to our partners in industry Lesley and Kelly with Johnson & Johnson for making this possible. My first time in Penticton and it was stunning.

Morning run in the inner harbour comparing notes with the best, Cory Ramstead MD, after last night’s case discussion on ...
02/14/2025

Morning run in the inner harbour comparing notes with the best, Cory Ramstead MD, after last night’s case discussion on the new TECNIS PureSee fully refractive EDOF. There has never been a better time to be a cataract and refractive surgeon.

Many of the best discussions in cataract and refractive surgery occur while wearing shorts. It was a pleasure to see so ...
02/02/2025

Many of the best discussions in cataract and refractive surgery occur while wearing shorts. It was a pleasure to see so many friends and join the faculty of 2025!

Had an amazing morning with colleagues discussing the surgical management of astigmatism and early experience with a nov...
06/08/2024

Had an amazing morning with colleagues discussing the surgical management of astigmatism and early experience with a novel full-range of vision IOL.

Address

4935 40 Avenue NW #450
Calgary, AB
T3A2N1

Alerts

Be the first to know and let us send you an email when Dr. Adam Muzychuk posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Featured

Share